In older adults with preclinical Alzheimer's disease (AD), learning curves derived from validated psychological learning paradigms are reduced to an extent greater than impairment, or decline, on neuropsychological memory tests.
Objective
This study aimed to examine how age, sex, education, mood, and general dementia risk, which also increases risk for preclinical AD, could influence learning curves.
Methods
1050 adults enrolled in the BetterBrains trial completed 10 blocks of ORCA-LLT learning trials over 5 days. Learning curves were derived from improvement in accuracy over trials. Participants also completed questionnaires of demography and mood, and the CAIDE risk score was computed for each participant.
Results
Most participants (67%) completed ≥6 blocks of ORCA-LLT. Older age (d = 0.75), lower education (d = 0.50), and higher dementia risk (d = 0.36) were associated significantly with slower learning rates.
Conclusions
In older adults, learning curves are influenced subtly by age, education, and dementia risk but not by sex or mood.
JackCRKnopmanDSJagustWJ, et al.Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol2013; 12: 207–216.
2.
SperlingRAAisenPSBeckettLA, et al.Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement2011; 7: 280–292.
3.
BakerJELimYYPietrzakRH, et al.Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: a meta-analysis. Alzheimers Dement (Amst)2017; 6: 108–121.
4.
JuttenRJGrandoitEFoldiNS, et al.Lower practice effects as a marker of cognitive performance and dementia risk: a literature review. Alzheimers Dement (Amst)2020; 12: e12055.
5.
HassenstabJRuvoloDJasielecM, et al.Absence of practice effects in preclinical Alzheimer's disease. Neuropsychology2015; 29: 940–948.
6.
DuffKFosterNLHoffmanJM. Practice effects and amyloid deposition: preliminary data on a method for enriching samples in clinical trials. Alzheimer Dis Assoc Disord2014; 28: 247–252.
7.
LeeSCChienTHChuCP, et al.Practice effect and test-retest reliability of the Wechsler Memory Scale-Fourth Edition in people with dementia. BMC Geriatr2023; 23: 209.
8.
Franco-MarinaFGarcía-GonzálezJJWagner-EcheagarayF, et al.The Mini-mental State Examination revisited: ceiling and floor effects after score adjustment for educational level in an aging Mexican population. Int Psychogeriatr2010; 22: 72–81.
9.
GoldbergTEKeefeRSEGoldmanRS, et al.Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies. Neuropsychopharmacology2010; 35: 1053–1062.
10.
LimYYBakerJEBruns JrL, et al.Association of deficits in short-term learning and Aβ and hippocampal volume in cognitively normal adults. Neurology2020; 95: 2577–2585.
11.
EbbinghausH. Memory: a contribution to experimental psychology. Ann Neurosci1885; 20: 155–157.
12.
BreitensteinCJansenADeppeM, et al.Hippocampus activity differentiates good from poor learners of a novel lexicon. Neuroimage2005; 25: 958–968.
13.
BreitensteinCKnechtS. Development and validation of a language learning model for behavioral and functional-imaging studies. J Neurosci Methods2002; 114: 173–179.
14.
LimYYAytonDPerinS, et al.An online, person-centered, risk factor management program to prevent cognitive decline: protocol for a prospective behavior-modification blinded endpoint randomized controlled trial. J Alzheimers Dis2021; 83: 1603–1622.
15.
BakerJEBruns JrLHassenstabJ, et al.Use of an experimental language acquisition paradigm for standardized neuropsychological assessment of learning: a pilot study in young and older adults. J Clin Exp Neuropsychol2020; 42: 55–65.
16.
LimYYEllisKAHarringtonK, et al.Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarker and Lifestyle (AIBL) study. J Clin Exp Neuropsychol2012; 34: 345–358.
17.
PerinSBuckleyRFPaseMP, et al.Unsupervised assessment of cognition in the Healthy Brain Project: implications for web-based registries of individuals at risk of Alzheimer's disease. Alzheimers Dement (N Y)2020; 6: e12043.
18.
LimYYVillemagneVLPietrzakRH, et al.APOE Epsilon4 moderates amyloid-related memory decline in preclinical Alzheimer's disease. Neurobiol Aging2015; 36: 1239–1244.
19.
StephenRLiuYNganduT, et al.Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition. J Alzheimers Dis2017; 59: 695–705.
20.
ToleaMIHeoJChrisphonteS, et al.A modified CAIDE (mCAIDE) risk score as a screening tool for cognitive impairment in older adults. J Alzheimers Dis2021; 82: 1755–1768.
21.
CohenJ. A power primer. Psychol Bull1992; 112: 155–159.
22.
WeinerMWAaronsonAEichenbaumJ, et al.Brain health registry updates: an online longitudinal neuroscience platform. Alzheimers Dement2023; 19: 4935–4951.
23.
LumsdenJSkinnerACoyleD, et al.Attrition from web-based cognitive testing: a repeated measures comparison of gamification techniques. J Med Internet Res2017; 19: e395.
24.
NicosiaJAschenbrennerAJBalotaDA, et al.Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's disease. J Int Neuropsychol Soc2023; 29: 459–471.
25.
LimYYBakerJEMillsA, et al.Learning deficit in cognitively normal APOE ε4 carriers with low β-amyloid. Alzheimers Dement (Amst)2021; 13: e12136.
26.
SteibelNMOlchikMRYassudaMS, et al.Influence of age and education on the Rivermead Behavioral Memory Test (RBMT) among healthy elderly. Dement Neuropsychol2016; 10: 26–30.
27.
HeidingerTLehrnerJ. Comparing a visual and verbal semantic memory test on the effects of gender, age and education as assessed in a cognitively healthy sample : a pilot study in the development of the international neuropsychological test profile-a tablet-based cognitive assessment. Neuropsychiatrie2020; 34: 140–147.
28.
HarringtonKDLimYYAmesD, et al.Using robust normative data to investigate the neuropsychology of cognitive aging. Arch Clin Neuropsychol2017; 32: 142–154.
29.
van der FlierWMSkoogISchneiderJA, et al.Vascular cognitive impairment. Nat Rev Dis Primers2018; 15: 18003.
30.
BurnhamSCBourgeatPDoreV, et al.Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study. Lancet Neurol2016; 15: 1044–1053.
31.
DuffKHammersDBDalleyBCA, et al.Short-term practice effects and amyloid deposition: providing information above and beyond baseline cognition. J Prev Alzheimers Dis2017; 4: 87–92.
32.
PappKVJuttenRJSoberanesD, et al.Early detection of amyloid-related changes in memory among cognitively unimpaired older adults with daily digital testing. Ann Neurol2024; 95: 507–517.
33.
SamarooAHBurnhamSCAmariglioR, et al.Diminished practice effects on a monthly computerized and home-administered face-name associative memory exam are predictive of elevated PET amyloid in normal older adult. Alzheimers Dement2019; 15: 47.
34.
BransbyLRosenichEMaruffP, et al.How modifiable are modifiable dementia risk factors? A framework for considering the modifiability of dementia risk factors. J Prev Alzheimers Dis2024; 11: 22–37.
